A novel oleanolic acid-loaded PLGA-TPGS nanoparticle for liver cancer treatment

References

• El-Serag HB. Hepatocellular carcinoma: an epidemiologic view. J Clin Gastroenterol 2002;35:S72–8
   PubMed Web of Science ®Google Scholar
• Rossi L, Zoratto F, Papa A, et al. Current approach in the treatment of hepatocellular carcinoma. World J Gastrointest Oncol 2010;2:348–59
   PubMedGoogle Scholar
• Doyle MB, Vachharajani N, Maynard E, et al. Liver transplantation for hepatocellular carcinoma: long-term results suggest excellent outcomes. J Am Coll Surg 2012;215:19–28
   PubMed Web of Science ®Google Scholar
• Li S, Hawxby AM, Kanagala R, et al. Liver transplantation for hepatocellular carcinoma: indications, bridge therapy and adjuvant therapy. J Okla State Med Assoc 2012;105:12–16
   PubMedGoogle Scholar
• Nussbaumer S, Bonnabry P, Veuthey JL, et al. Analysis of anticancer drugs: a review. Talanta 2011;85:2265–89
   PubMed Web of Science ®Google Scholar
• Hossain DM, Bhattacharyya S, Das T, Sa G. Curcumin: the multi-targeted therapy for cancer regression. Front Biosci (Schol Ed) 2012;4:335–55
   PubMedGoogle Scholar
• Manchun S, Dass CR, Sriamornsak P. Targeted therapy for cancer using pH-responsive nanocarrier systems. Life Sci 2012;90:381–7
   PubMed Web of Science ®Google Scholar
• Tsuruga T, Chun YT, Ebizuka Y, Sankawa U. Biologically active constituents of Melaleuca leucadendron: inhibitors of induced histamine release from rat mast cells. Chem Pharm Bull 1991;39:3276–8
   PubMed Web of Science ®Google Scholar
• Balanehru S, Nagarajan B. Protective effect of oleanolic acid and ursolic acid against lipid peroxidation. Biochem Int 1991;24:981–90
   PubMedGoogle Scholar
• Zhang YN, Zhang W, Hong D, et al. Oleanolic acid and its derivatives: new inhibitor of protein tyrosine phosphatase 1B with cellular activities. Bioorg Med Chem 2008;16:8697–705
   PubMed Web of Science ®Google Scholar
• Shibata S. Chemistry and cancer preventing activities of ginseng saponins and some related triterpenoid compounds. J Korean Med Sci 2001;16:S28–37
   PubMed Web of Science ®Google Scholar
• Yan SL, Huang CY, Wu ST, Yin MC. Oleanolic acid and ursolic acid induce apoptosis in four human liver cancer cell lines. Toxicol In Vitro 2010;24:842–8
   PubMed Web of Science ®Google Scholar
• Shyu MH, Kao TC, Yen GC. Oleanolic acid and ursolic acid induce apoptosis in HuH7 human hepatocellular carcinoma cells through a mitochondrial-dependent pathway and downregulation of XIAP. J Agric Food Chem 2010;58:6110–18
   PubMed Web of Science ®Google Scholar
• Ovesná Z, Vachálková A, Horváthová K, Tóthová D. Pentacyclic triterpenoic acids: new chemoprotective compounds. Minireview. Neoplasma 2004;5:327–33
   Google Scholar
• Novotný L, Vachálková A, Biggs D. Ursolic acid: an antitumorigenic and chemopreventive activity. Neoplasma 2001;48:241–6
   PubMed Web of Science ®Google Scholar
• Zhou S, Xu J, Yang H, Deng X. Synthesis and characterization of biodegradable poly(ɛ-caprolactone)-poly glycolide-poly(ethylene glycol) monomethyl ether random copolymer. Macromol Mater Eng 2004;289:576–80
   Google Scholar
• Traber MG, Schiano TD, Steephen AC, et al. Efficacy of water-soluble vitamin E in the treatment of vitamin-E malabsorption in short-bowel syndrome. Am J Clin Nutr 1994;59:1270–4
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release 2003;86:33–48
   PubMed Web of Science ®Google Scholar
• Ling Y, Huang YS. Preparation and release efficiency of poly (lactic-co-glycolic) acid nanoparticles for drug loaded paclitaxel. In: Peng Y, Wen X, eds. Seventh Asian-Pacific conference on medical and biological engineering APCMBE. IFMBE Proceedings. Berlin, Heidelberg: Springer; 2008:514–17
   Google Scholar
• Fischer JR, Harkin KR, Freeman LC. Concurrent administration of water-soluble vitamin E can increase the oral bioavailability of cyclosporine A in healthy dogs. Vet Ther 2002;3:465–73
   PubMedGoogle Scholar
• Dintaman JM, Silverman JA. Inhibition of P-glycoprotein by d-α-tocopheryl polyethylene glycol 1000 succinate (TPGS). Pharm Res 1999;16:1550–6
   PubMed Web of Science ®Google Scholar
• Yu L, Bridgers A, Polli J, et al. Vitamin E-TPGS increases absorption flux of an HIV protease inhibitor by enhancing its solubility and permeability. Pharm Res 1999;16:1812–17
   PubMed Web of Science ®Google Scholar
• Chen H, Zheng Y, Tian G, et al. Oral delivery of DMAB-modified docetaxel-loaded PLGA-TPGS nanoparticles for cancer chemotherapy. Nanoscale Res Lett 2011;6:4–14
   PubMed Web of Science ®Google Scholar
• Ishiyama M, Tominaga H, Shiga M, et al. A combined assay of cell viability and in vitro cytotoxicity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharmaceut Bull 1996;19:1518–20
   PubMed Web of Science ®Google Scholar
• Desai MP, Labhasetwar V, Walter E, et al. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res 1997;14:1568–73
   PubMed Web of Science ®Google Scholar
• Qaddoumi MG, Ueda H, Yang J, et al. The characteristic and mechanisms of PLGA nanoparticles in rabbit conjunctival epithelial cell layers. Pharm Res 2004;21:641–8
   PubMed Web of Science ®Google Scholar
• Mei L, Zhang Y, Zheng Y, et al. A novel docetaxel-loaded poly(ɛ-caprolactone)/pluronic F68 nanoparticle overcoming multidrug resistance for breast cancer treatment. Nanoscale Res Lett 2009;4:1530–9
   PubMed Web of Science ®Google Scholar
• Florence AT. Nanoparticle uptake by the oral route: fulfilling its potential? Drug Discovery Today Technol 2005;2:75–81
   PubMedGoogle Scholar
• Norris DA, Puri N, Sinko PJ. The effect of physical barriers and properties on the oral absorption of particulates. Adv Drug Deliv Rev 1998;34:135–54
   PubMed Web of Science ®Google Scholar
• Zhang ZR, He Q. Study on liver targeting and hepatocytes permeable valaciclovir polybutylcyanoa-cryslate nanoparticles. World J Gastroenterol 1999;5:330–3
   PubMed Web of Science ®Google Scholar
• Cho CS, Kobayashi A, Takei R, et al. Receptor-mediated cell modulator delivery to hepatic using nanoparticles coated with carbohydrate–carryin polymers. Bioamaterials 2001;22:45–51
   PubMed Web of Science ®Google Scholar
• Owens DE, Peppas NA. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006;307:93–102
   PubMed Web of Science ®Google Scholar
• Murakami H, Kawashima Y, Niwa T, et al. Influence of the degrees of hydrolyzation and polymerization of poly(vinyl-alcohol)on the preparation and properties of poly(dl-lactide-co-glycolide) nanoparticle. Int J Pharm 1997;149:43–9
   Web of Science ®Google Scholar
• Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. Preparation of poly (dl-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int J Pharm 1999;187:143–52
   PubMed Web of Science ®Google Scholar
• Banker GS. Modern pharmaceutics, 3rd ed. New York: Marcel Dekker Inc; 1955;593–9, 611–80
   Google Scholar
• Feng SS, Mu L, Win KY, Huang G. Nanoparticles of biodegradable polymers for clinical administration of paclitaxel. Curr Med Chem 2004;11:413–24
   PubMed Web of Science ®Google Scholar
• Mu L, Feng SS. Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxols). J Control Release 2002;80:129–44
   PubMed Web of Science ®Google Scholar
• Zhang Z, Mei L, Feng SS. Vitamin E d-a-tocopheryl polyethylene glycol 1000 succinate-based nanomedicine. Nanomedicine 2012;7:1645–7
   PubMed Web of Science ®Google Scholar
• Zhu H, Chen H, Zeng X, et al. Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance. Biomaterials 2014;35:2391–400
   PubMed Web of Science ®Google Scholar
• Dobrozsi D. Oral liquid mucoadhesive compositions. US Patent Appl. No. 10/021, 327;2001
   Google Scholar
• Jin C, Bai L, Wu H, et al. Radio sensitization of paclitaxel, etanidazole and paclitaxel + etanidazole nanoparticles on hypoxic human tumor cells in vitro. Biomaterials 2007;28:3724–30
   PubMed Web of Science ®Google Scholar
• Sengel-Türk CT, Hasçiçek C, Dogan AL, et al. Preparation and in vitro evaluation of meloxicam-loaded PLGA nanoparticles on HT-29 human colon adenocarcinoma cells. Drug Dev Ind Pharm 2012;38:1107–16
   PubMed Web of Science ®Google Scholar
• Rejman J, Oberle V, Zuhorn IS, Hoekstra D. Size-dependent internalization of particle via the pathways of clathrin-and caveolae-mediated endocytosis. Biochem J 2004;377:159–69
   PubMed Web of Science ®Google Scholar
• Chen J, Li S, Shen Q, et al. Enhanced cellular uptake of folic acid-conjugated PLGA-PEG nanoparticles loaded with vincristine sulfate in human breast cancer. Drug Dev Ind Pharm 2011;37:1339–46
   PubMed Web of Science ®Google Scholar
• Win KY, Feng SS. Effects of particle size and surface coating on cellular uptake of polymeric nanoparticles for oral delivery of anticancer drugs. Biomaterials 2005;26:2713–22
   PubMed Web of Science ®Google Scholar
• Batrakova EV, Kabanov AV. Pluronic block copolymers: evolution of drug delivery concept from inert nanocarriers to biological response modifiers. J Control Release. 2008;130:98–106
   PubMed Web of Science ®Google Scholar
• Yang Z, Sahay G, Sriadibhatla S, Kabanov AV. Amphiphilic block copolymers enhance cellular uptake and nuclear entry of polyplex-delivered DNA. Bioconjug Chem 2008;19:1987–94
   PubMed Web of Science ®Google Scholar
• Davda J, Labhasetwar V. Characterization of nanoparticle uptake by endothelial cells. Int J Pharm 2002;233:51–9
   PubMed Web of Science ®Google Scholar
• Bogman K, Erne-Brand F, Alsenz J, Drewe J. The role of surfactants in the reversal of active transport mediated by multidrug resistance proteins. J Pharm Sci 2003;92:1250–61
   PubMed Web of Science ®Google Scholar
• Brigger I, Dubernet C, Couvreur P. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 2002;54:631–51
   PubMed Web of Science ®Google Scholar
• Rege BD, Kao JP, Polli JE. Effects of nonionic surfactants on membrane transporters in Caco-2 cell monolayers. Eur J Pharm Sci 2002;16:237–46
   PubMed Web of Science ®Google Scholar
• Bogman K, Zysset Y, Degen L, et al. P-glycoprotein and surfactants: effect on intestinal talinolol absorption. Clin Pharmacol Therap 2005;77:24–32
   PubMed Web of Science ®Google Scholar
• Ma Y, Zheng Y, Zeng X, et al. Novel docetaxel-loaded nanoparticles based on PCL-Tween 80 copolymer for cancer treatment. Nanoscale Res Lett 2010;57:1161–9
   Web of Science ®Google Scholar